Stryker Sells U.S. Spinal Implants Business
Stryker to sell spinal implants business
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter. Stryker’s spinal implants business brought in $707 million in sales in 2024, and Lobo clarified that the “entire $700 million is expected to be divested to [VB Spine].”
Stryker to spin off spinal implant business, as Viscogliosi Brothers-owned VB Spine
Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to divest its international enterprises in the months to come. | Stryker is selling off its spine implant business—starting with a plan to spin off its U.
Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
In a report released today, Michael Matson from Needham reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...
NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab ... outperforming a bigger decline in the S&P 500 Health Care Equipment index (.SPLRCMED), opens new tab.
“Stryker recognizes the power of Inari’s portfolio ... according to Biocom California’s Life Science Economic Impact Report. They report that medical devices and equipment were the largest ...
Stryker (SYK) announced that it is commencing ... all of the issued and outstanding shares of common stock of Inari Medical (NARI) for $80.00 per share in cash. The offer is being made pursuant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback